Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice
- PMID: 20577047
- PMCID: PMC2898582
- DOI: 10.1172/JCI38291
Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice
Abstract
Steroid hormone receptors function classically in the nucleus as transcription factors. However, recent data indicate that there are also non-nuclear subpopulations of steroid hormone receptors, including estrogen receptors (ERs), that mediate membrane-initiated signaling of unclear basis and significance. Here we have shown that an estrogen-dendrimer conjugate (EDC) that is excluded from the nucleus stimulates endothelial cell proliferation and migration via ERalpha, direct ERalpha-Galphai interaction, and endothelial NOS (eNOS) activation. Analysis of mice carrying an estrogen response element luciferase reporter, ER-regulated genes in the mouse uterus, and eNOS enzyme activation further indicated that EDC specifically targets non-nuclear processes in vivo. In mice, estradiol and EDC equally stimulated carotid artery reendothelialization in an ERalpha- and G protein-dependent manner, and both agents attenuated the development of neointimal hyperplasia following endothelial injury. In contrast, endometrial carcinoma cell growth in vitro and uterine enlargement and MCF-7 cell breast cancer xenograft growth in vivo were stimulated by estradiol but not EDC. Thus, EDC is a non-nuclear selective ER modulator (SERM) in vivo, and in mice, non-nuclear ER signaling promotes cardiovascular protection. These processes potentially could be harnessed to provide vascular benefit without increasing the risk of uterine or breast cancer.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2898582/bin/JCI38291.f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2898582/bin/JCI38291.f2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2898582/bin/JCI38291.f3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2898582/bin/JCI38291.f4.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2898582/bin/JCI38291.f5.gif)
![Figure 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2898582/bin/JCI38291.f6.gif)
![Figure 7](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2898582/bin/JCI38291.f7.gif)
Comment in
-
Rapid progress for non-nuclear estrogen receptor signaling.J Clin Invest. 2010 Jul;120(7):2277-9. doi: 10.1172/JCI43756. Epub 2010 Jun 23. J Clin Invest. 2010. PMID: 20577045 Free PMC article. Review.
Similar articles
-
Non-nuclear estrogen receptor alpha activation in endothelium reduces cardiac ischemia-reperfusion injury in mice.J Mol Cell Cardiol. 2017 Jun;107:41-51. doi: 10.1016/j.yjmcc.2017.04.004. Epub 2017 Apr 27. J Mol Cell Cardiol. 2017. PMID: 28457941 Free PMC article.
-
Non-nuclear estrogen receptor signaling in the endothelium.J Biol Chem. 2011 Apr 29;286(17):14737-43. doi: 10.1074/jbc.R110.191791. Epub 2011 Feb 22. J Biol Chem. 2011. PMID: 21343284 Free PMC article. Review.
-
Rapid progress for non-nuclear estrogen receptor signaling.J Clin Invest. 2010 Jul;120(7):2277-9. doi: 10.1172/JCI43756. Epub 2010 Jun 23. J Clin Invest. 2010. PMID: 20577045 Free PMC article. Review.
-
Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors.Mol Endocrinol. 2008 Sep;22(9):2116-27. doi: 10.1210/me.2008-0059. Epub 2008 Jul 10. Mol Endocrinol. 2008. PMID: 18617595 Free PMC article.
-
Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk.J Biol Chem. 2002 Mar 8;277(10):8531-7. doi: 10.1074/jbc.M109592200. Epub 2001 Dec 21. J Biol Chem. 2002. PMID: 11751931
Cited by
-
Reprogramming of endothelial gene expression by tamoxifen inhibits angiogenesis and ERα-negative tumor growth.Theranostics. 2024 Jan 1;14(1):249-264. doi: 10.7150/thno.87306. eCollection 2024. Theranostics. 2024. PMID: 38164151 Free PMC article.
-
Roles of estrogen receptor α in endometrial carcinoma (Review).Oncol Lett. 2023 Oct 25;26(6):530. doi: 10.3892/ol.2023.14117. eCollection 2023 Dec. Oncol Lett. 2023. PMID: 38020303 Free PMC article. Review.
-
Peering into the Brain's Estrogen Receptors: PET Tracers for Visualization of Nuclear and Extranuclear Estrogen Receptors in Brain Disorders.Biomolecules. 2023 Sep 18;13(9):1405. doi: 10.3390/biom13091405. Biomolecules. 2023. PMID: 37759805 Free PMC article.
-
Role of estrogen in the regulation of central and peripheral energy homeostasis: from a menopausal perspective.Ther Adv Endocrinol Metab. 2023 Sep 15;14:20420188231199359. doi: 10.1177/20420188231199359. eCollection 2023. Ther Adv Endocrinol Metab. 2023. PMID: 37719789 Free PMC article. Review.
-
Endothelial ERα promotes glucose tolerance by enhancing endothelial insulin transport to skeletal muscle.Nat Commun. 2023 Aug 17;14(1):4989. doi: 10.1038/s41467-023-40562-w. Nat Commun. 2023. PMID: 37591837 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous